You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海爾生物(688139.SH)網上搖號中籤號碼60402個 國泰君安證裕投資獲配317.07萬股
格隆匯 10-17 19:52

格隆匯10月17日丨海爾生物(688139.SH)發佈首次公開發行股票並在科創板上市網下初步配售結果及網上中籤結果公告,具體如下:

戰略配售結果:國泰君安證裕投資有限公司獲配股數317.0718萬股。

網上搖號中籤結果:中籤號碼共有60,402個,每箇中籤號碼只能認購500海爾生物股票。

網下初步配售結果:

發行人與薦機構(主承銷商)定於20191021日(T+3日)上午在上海市浦東東方路778 號紫金山大酒店四樓會議室海棠廳進行本次發行網下限售賬户的搖號抽籤,並將於20191022公佈網下限售賬户搖號中籤結果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account